Lipids and glucose in type 2 diabetes: what is the cause and effect?
about
When is a high fat diet not a high fat diet?Isosteviol has beneficial effects on palmitate-induced α-cell dysfunction and gene expressionCOH-SR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese miceThe characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population.Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Hip circumference and the risk of type 2 diabetes in middle-aged and elderly men and women: the Shanghai women and Shanghai men's health studies.Insulin detemir for the treatment of obese patients with type 2 diabetes.Diabetes and hypertension: is there a common metabolic pathway?Nonequilibrium thermodynamics and energy efficiency in weight loss diets.Pioglitazone and sulfonylureas: effectively treating type 2 diabetesEffects of Ghrelin on Triglyceride Accumulation and Glucose Uptake in Primary Cultured Rat Myoblasts under Palmitic Acid-Induced High Fat ConditionsRecent findings concerning thiazolidinediones in the treatment of diabetes.Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis studyAssociation of curry consumption with blood lipids and glucose levels.Effect of current glycemic control on qualitative body composition in sedentary ambulatory Type 2 diabetics.Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal.Relation between serum free fatty acids and adiposity, insulin resistance, and cardiovascular risk factors from adolescence to adulthood.The characteristics of pre-diabetic patients associated with body composition and cardiovascular disease risk factors in the Iranian population.Peroxisome proliferator-activated receptor activating hypoglycemic effect of Gardenia jasminoides Ellis aqueous extract and improvement of insulin sensitivity in steroid induced insulin resistant rats.Protection of palmitic acid-mediated lipotoxicity by arachidonic acid via channeling of palmitic acid into triglycerides in C2C12.Telmisartan: a different angiotensin II receptor blocker protecting a different population?The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes: 'To store or not to store glucose, that's the question'.Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy.Lipolysis and glycerol gluconeogenesis in simultaneously fasting and lactating northern elephant seals.Glucose metabolism during lactation in a fasting animal, the northern elephant seal.Concomitant intake of quercetin with a grain-based diet acutely lowers postprandial plasma glucose and lipid concentrations in pigs.Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes.Nutrient intakes and dysglycaemia in populations of West African origin.Exploring the pharmacotherapeutic options for treating type 2 diabetes.InsuTAG: A novel physiologically relevant predictor for insulin resistance and metabolic syndrome.Metabolomics study of diabetic retinopathy using gas chromatography-mass spectrometry: a comparison of stages and subtypes diagnosed by Western and Chinese medicine.The Effect of Boron on Some Biochemical Parameters in Experimental Diabetic Rats.Ginsenoside Rb1 exerts antidiabetic action on C2C12 muscle cells by leptin receptor signaling pathway.Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases.Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders
P2860
Q24817175-05D5278F-7AF0-4F57-8734-E29A4CB18253Q28481674-9DD0398F-2843-4A2C-A338-EBCD3F4BCF48Q28537870-000F5413-3E2E-4929-934A-FC8A2B1ADE1FQ33541335-3F14C76D-DF32-4676-9A80-D2B05E4B51ECQ34591803-C70AA430-B2A9-4E53-9F4A-03B2C7E00146Q35062610-037968DC-C76F-4661-9B74-708FC3CC4255Q35703041-2C9F96FD-D9E2-47C2-A0AF-5190C7847224Q35857205-6BDD4750-9E0C-43CE-92C8-5CB62675FBEAQ35939829-461E1ADB-695D-4590-9698-0B9AF3DAF68CQ35987456-EB111A75-35DB-40C3-8CDE-A08DF1D5B55BQ36374624-C68AAA20-B392-4D24-BE08-5D6C6B12FBEEQ36407304-9F8EC657-9FF3-4A84-9D5F-27B0EB0C935CQ36736511-792A66EA-9925-43F5-AF6A-88528394ECCEQ36760498-35B6A4E9-BC6D-49CA-B23C-B6CC8E901E02Q36876717-BDE4396B-4A96-4AC0-BD24-6818F070E0A2Q36956584-FF16D3E9-1019-41A8-BBEF-B384074E8D9CQ37110607-E352B8D2-CDE3-4E28-9C50-B5FB07022265Q37436943-CB8FBC98-BE02-4AA1-A27D-656ABDED27E8Q37501666-C7E72F0E-E544-4122-8A06-FE4E7E30057DQ37588127-9CC8FB8E-3AFD-488B-A8E0-FDBD6057FD62Q37690442-29E4AAF3-250D-4C24-92FA-218AE7345CC0Q38038512-A28D7A1C-67C4-4CE9-A178-E9994179BDCDQ38086841-14EF954C-203B-4AF7-8064-8FC7F95503A3Q38700428-8D09720B-7952-41D5-8763-157EB0B9375AQ38701168-7A9C4071-EE7F-4C47-A8A4-552A700BC088Q39196470-7C26619F-1AF3-4546-A61F-BEB29DFB13ACQ43109251-0AE902C2-09CE-4E1B-9105-DFA65B43CFFCQ43810772-E0BE8010-0B89-4F5E-976C-E718195AC2E3Q43994439-90323A01-1024-4333-9966-CA8A7CE41AFCQ46135329-937C6CC5-8F26-4A85-BC15-468704BDE87EQ47299139-D6059479-9D5B-45A3-A6DA-F399FBAC267BQ48212191-FD60B29D-E4EA-41E4-892C-BD82C159EC9FQ50973299-9C4D3552-514C-4A3F-99B5-7F2664FD41A4Q52606244-677AB2B4-200E-4B93-91D1-7C4656222D46Q58735820-F35080C2-5C58-4350-B0EC-006E2A60BCF0
P2860
Lipids and glucose in type 2 diabetes: what is the cause and effect?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@ast
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@en
type
label
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@ast
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@en
prefLabel
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@ast
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@en
P1433
P1476
Lipids and glucose in type 2 diabetes: what is the cause and effect?
@en
P2093
Guenther Boden
Markku Laakso
P304
P356
10.2337/DIACARE.27.9.2253
P407
P577
2004-09-01T00:00:00Z